On the 25th d, adult survival was 38%, 28%, 44%, and 31% for the
control, pymetrozine, pyriproxyfen, and rynaxypyr treatments,
respectively, and 6%, 14%, 6%, and 5%, respectively, after 37 d
(Fig. 2).
On the 25th d, adult survival was 38%, 28%, 44%, and 31% for thecontrol, pymetrozine, pyriproxyfen, and rynaxypyr treatments,respectively, and 6%, 14%, 6%, and 5%, respectively, after 37 d(Fig. 2).
การแปล กรุณารอสักครู่..